A Rare but Aggressive Renal Manifestation of IgA Vasculitis in an 11-Year-Old Girl
Keywords:
Henoch–Schönlein purpura, HSP nephritis, crescentic glomerulonephritis, pediatric patient, vasculitis, immunosuppressive therapy, renal biopsyAbstract
Although rare, crescentic Henoch–Schönlein purpura (HSP) nephritis poses a significant diagnostic and therapeutic challenge due to its variable clinical presentation and unpredictable disease course. Crescentic HSP nephritis is a severe manifestation accounting for less than 5% of HSP nephritis cases and is associated with rapid deterioration of renal function, potentially progressing to end-stage renal disease if not promptly treated. Early diagnosis, close monitoring, and timely recognition of complications are essential for initiating appropriate management and preserving renal function. Lifestyle modifications, including dietary regulation and physical activity, may contribute to symptom control and improvement in overall health. Renal involvement in HSP typically presents with hematuria and mild to moderate proteinuria; however, crescentic involvement represents a more aggressive pathological variant requiring intensive therapy.
Downloads
References
Pohl M. Henoch–Schönlein purpura nephritis in children. Nat Rev Nephrol. 2015;11(9):563–573.
Narchi H. Henoch–Schönlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr. 2019;15(2):135–145.
Dudley J, Smith G, Llewellyn-Edwards A. Therapy for children with Henoch–Schönlein purpura nephritis: a systematic review. Int J Nephrol. 2013;2013:1–10.
Coppo R, Andrulli S, Amore A. Clinical outcome in children with Henoch–Schönlein nephritis. Pediatr Nephrol. 2006;21(3):354–360.
Bogdanović R. Henoch–Schönlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr. 2009;98(12):1882–1889.
Chang WL, Yang YH, Lin YT. Association between allergic diseases and risks of HSP nephritis. Pediatr Res. 2016;79(4):559–565.
Sharma A, et al. Crescentic glomerulonephritis in pediatric HSP. Saudi J Med Allied Sci. 2021;9:1035–1040.
Weiss PF. Drug treatments for nephritis in children with IgA vasculitis. Clin Rheumatol. 2018;37(6):1523–1532.
Pillebout E, et al. Comparison between adults and children with HSP nephritis. Pediatr Nephrol. 2017;32(3):459–466.
Wang Y, et al. Urinary MCP-1 levels in children with HSP nephritis. Clin Nephrol. 2012;78(5):388–395.
Kawasaki Y. Pathogenesis and treatment of pediatric HSP nephritis. Clin Exp Nephrol. 2011;15(5):648–657.
Sinha R, et al. Henoch–Schönlein purpura nephritis in children: prognosis and treatment experiences. J Pediatr Nephrol. 2019;4(1):1–8.
Ronkainen J, et al. Long-term results in children with Henoch–Schönlein nephritis. Kidney Int. 2002;62(5):1681–1689.
Feng D, et al. HSP nephritis with nephrotic proteinuria in children. Pediatr Rheumatol. 2018;16(1):1–9.
Niaudet P. Henoch–Schönlein purpura nephritis. Pediatr Nephrol. 2016;31(7):1031–1043.
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

.